THE NICKLES GROUP, LLC for UCB, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376, the Build Back Better Act, as it relates to drug pricing. Monitored S. 3700 / H.R. 6833, Affordable Insulin Now Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
H.R. 5376, the Build Back Better Act, as it relates to orphan drug tax credit, corporate and international taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
S. 464 / H.R. 2163, the Safe Step Act and issues related to step therapy. Monitored FDA user fee legislation. Monitored issues related to mental health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
H.R. 2163, the Safe Step Act and issues related to prescription drug step therapy. H.R. 5376, the Build Back Better Act, as it relates to drug pricing. H.R. 7389, MVP Act, issues related to prescription drug value-based contracts. Monitored FDA user fee legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.